PATENT CLAIM ANALYSIS

Application Number: 15757133
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "266200"]

Abstract:
In one aspect the present disclosure provides a method of sensitizing a cancer patient to chemotherapy by administering a combination therapy comprising; a) a therapeutically effective amount of a compound of formula (I) an enantiomer thereof or a pharmaceutically acceptable salts of any one of the same, and b) a chemotherapeutic agent or a combination of chemotherapeutic agents.

Claim (Index 6):
A method according to  claim 4  or  5  wherein the chemotherapeutic comprises oxaliplatin.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15757189', '12807931', '12218470', '14581610', '11433079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7534685492991143
- 35 USC 102 Novelty (BERT): 0.53507871321413
- Combined Prediction Score: 0.7316295656906159
- Mean Citation Score: 242.32139
- Max Citation Score: 362.1345
- Similarity Product: 270.74240042746067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test